HomeCMMB • NASDAQ
add
Chemomab Therapeutics Ltd - ADR
Previous close
$1.57
Day range
$1.57 - $1.73
Year range
$1.35 - $5.84
Market cap
11.45M USD
Avg Volume
94.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.97M | -38.56% |
Net income | -1.87M | 36.79% |
Net profit margin | — | — |
Earnings per share | -0.00 | 90.62% |
EBITDA | -1.96M | 38.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.37M | -27.34% |
Total assets | 13.81M | -18.58% |
Total liabilities | 1.48M | -56.87% |
Total equity | 12.33M | — |
Shares outstanding | 7.19M | — |
Price to book | 0.92 | — |
Return on assets | -37.70% | — |
Return on capital | -41.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.87M | 36.79% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2011
Website
Employees
16
